The study met its Primary Endpoint of pain relief and showed that SPRINT PNS delivered significant improvements in patient-centric secondary endpointsCLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ...
SPR Therapeutics was one of seven companies that collectively secured $192 million in the first quarter of the year, according to the latest Venture Monitor report. SPR Therapeutics led venture ...
What if your college internship could directly impact the lives of patients, revolutionize medical technology, and connect you with an inspiring network of innovators? Junior Biomedical Engineering ...
CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American Society of Pain & Neuroscience ...
CLEVELAND, Dec. 13, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics has been named to the Crain’s Cleveland Business Fast 50, placing first on the list of rapidly growing, privately held companies ranked by ...
Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system. Cleveland, Ohio-based SPR Therapeutics announced today that it has ...
CLEVELAND, June 25, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics has been selected as a Top Workplaces honoree for the second year in a row by cleveland.com and The Plain Dealer. The Top Workplaces ...
CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain ...
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
SPR Therapeutics, a Cleveland medical device company, has secured $85 million in financing to advance the commercial expansion of its SPRINT PNS System, a non-opioid, minimally invasive pain treatment ...
CLEVELAND, Dec. 13, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics has been named to the Crain’s Cleveland Business Fast 50, placing first on the list of rapidly growing, privately held companies ranked by ...
CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics' SPRINT PNS System generated interest from leading pain physicians at the American Society of Pain & Neuroscience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback